Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice.
about
Potential Role of the Gut/Liver/Lung Axis in Alcohol-Induced Tissue PathologyContact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug deliveryTransitional Remodeling of the Hepatic Extracellular Matrix in Alcohol-Induced Liver InjuryHigh-resolution 3D volumetry versus conventional measuring techniques for the assessment of experimental lymphedema in the mouse hindlimb.Recent Advances in (19)Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions.Perfluorocarbon nanoparticles for physiological and molecular imaging and therapyPerfluorocarbon nanoparticles: evolution of a multimodality and multifunctional imaging agent.Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer.A fibrin-specific thrombolytic nanomedicine approach to acute ischemic strokeUltrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsionsRationale for a nanomedicine approach to thrombolytic therapy.Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions.Fumagillin prodrug nanotherapy suppresses macrophage inflammatory response via endothelial nitric oxide.Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis.Endothelial FAK as a therapeutic target in disease.Acute alcohol-induced liver injury.Molecular MR imaging of neovascular progression in the Vx2 tumor with αvβ3-targeted paramagnetic nanoparticlesMechanisms and cell signaling in alcoholic liver disease.Advances in rheumatoid arthritis animal models.Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism.Anti-angiogenic Nanotherapy Inhibits Airway Remodeling and Hyper-responsiveness of Dust Mite Triggered Asthma in the Brown Norway Rat.Characterization of early neovascular response to acute lung ischemia using simultaneous (19)F/ (1)H MR molecular imaging.Anti-angiogenesis therapy in the Vx2 rabbit cancer model with a lipase-cleavable Sn 2 taxane phospholipid prodrug using α(v)β₃-targeted theranostic nanoparticles.Nanotherapeutic approaches for the treatment of rheumatoid arthritis.Applying nanomedicine in maladaptive inflammation and angiogenesis.A key role for Fut1-regulated angiogenesis and ICAM-1 expression in K/BxN arthritis.Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrugPeptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis.Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles.Lipid-Based Nanoparticles as a Potential Delivery Approach in the Treatment of Rheumatoid Arthritis.Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.Fibrin-mediated integrin signaling plays a critical role in hepatic regeneration after partial hepatectomy in mice
P2860
Q26781989-659B946D-62E6-4534-B38C-116FEC55DF44Q26795703-3F30D96E-2BC7-4B54-A3EA-C4E7B71E49FEQ28071500-EBF933BA-8B8C-478A-8455-69AC153E6ECFQ30372575-206A4401-8246-47D1-BCE9-B5E6139303D9Q30385272-60B93FAB-94A3-41BE-8641-F1AE627D7D1EQ30426880-73A96242-22E3-4A5F-8F1B-A7E687B3CB47Q30434964-8F8333A1-EF9D-4B33-8CCE-F875E1696E9FQ30450131-D1A4C301-C01B-46CB-9638-DE1EDFB5E606Q30452739-0DD14E4D-4892-4D80-ADB8-D4C41E445191Q30465710-94AC3459-8624-4395-838B-9C0829BB13ADQ30474015-2F663679-F0EB-4157-8FC0-CA60F6822B99Q33684461-00711B2E-7D4C-4209-AA63-7B92F9DC07D0Q33939470-D6B1AE6D-9975-4321-BE3C-9434A0A76DF0Q34562028-708DEEFA-2D5D-4A9B-A83A-C6B045B07142Q35597214-9F69E897-B5E6-4981-9173-A8D4AB9A0FDFQ36025557-8DAB3BDF-8F1A-4372-8DB5-77A1E62FB619Q37039546-0D042A7B-386E-4AAD-87D2-4D5D85F9F8DBQ37127404-E47FB617-8750-40B6-B663-E398776CF168Q37205119-927AA9E5-465D-45D7-AE74-5B03DD6D2342Q37305691-BF895373-68DF-43AE-A007-4D86A3AA0F4FQ37541992-15C2A758-9F40-44CC-B94B-927AA56AE186Q37626285-3744E89F-8EAB-43DB-874B-F74876F537AEQ37695396-64D0ED6E-2CC8-4B7B-A052-5907E6D8B909Q37916426-05509C2A-FA33-48F9-BCD8-6D12D1BA4B81Q38557650-7EFACF4D-E689-49AE-A211-CD1A25C44623Q39012089-96536419-3468-4B5B-8FD5-EDE4BC7E181CQ41141263-2BB68A40-C814-4F3B-BA2F-2AAF4F5A65BFQ41860441-85E2FDBD-CE6F-470E-95F8-28A283553579Q41879624-4347C5FC-4631-4749-9821-D10A65DF1863Q48225327-D94D43E2-FBE6-4865-A4AB-A25F1A39F0B9Q55348014-1390CDCF-75E4-4645-828D-C73EB50880ADQ57211412-8EE6C952-ED2E-4F42-8706-91570A4A4D3E
P2860
Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice.
@en
Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice.
@nl
type
label
Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice.
@en
Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice.
@nl
prefLabel
Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice.
@en
Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice.
@nl
P2093
P2860
P356
P1433
P1476
Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice.
@en
P2093
Christine T N Pham
Gregory M Lanza
Happy W Chan
Hui-Fang Zhou
Samuel A Wickline
P2860
P304
P356
10.1096/FJ.09-129874
P407
P577
2009-04-17T00:00:00Z